Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...

The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...

It is not every day that you see crude oil prices moving higher and the Asian markets, including India, also inching higher. Now, as an inv...

Army settlements are present in Malari that comes under Joshimath tehsil which has been in the news for its land subsidence crisis. "Severa...

Border Roads Organisation on Sunday said a valley bridge near the India-China border, nine km ahead of Malari village here has come under t...

Several workers were deployed to dismantle the Inn. The road near hotel Malari Inn was blocked and police and State Disaster Response Fund ...

On Monday, District Magistrate Himanshu Khurana informed that a central team would arrive in Chamoli district to survey the damage wrought ...

Elise Malary has been found dead in Lake Michigan. She was an activist for transgender people and was missing for more than a week. She bel...

The bridge is near Reini village of the district and it was opened for public use on Wednesday, said the Defence Ministry's statement.

The company expects significant rise in the revenue from exports to Africa after the introduction of this injection in the African market.

Pharma firm Nutraplus India has started commercial production of anti-malarial drug Lumefantrine at its new plant at Tarapur in Maharashtra.

The need for a vaccine to control malaria has become important because of emerging resistance to existing anti-malarial pills.

Dr Datsons Labs today said it has inked marketing and supply agreement with Yemen's Al-Mugdh Pharma to sell its anti-malarial drugs in Yemen

Drug firm Strides Arcolab today said it has received World Health Organisation (WHO) pre- qualification for its anti-malarial tablets.

IPCA Labs, a mid-sized Indian pharma company, has seen its stock price doubling in the past six months.

IPCA Laboratories and Central Drug Research Institute (CDRI) will develop a synthetic substitute of anti-malarial drugs.

: In a major breakthrough, biochemists of the Indian Institute of Science, Bangalore have found that the anti-cancer drug and the inhibitor...